Kalehua Capital Management as of June 30, 2026
Portfolio Holdings for Kalehua Capital Management
Kalehua Capital Management holds 26 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ea Series Trust Alpha Arch 1-3 (BOXX) | 15.2 | $27M | 226k | 117.09 | |
| Veradermics Common Stock (MANE) | 10.3 | $18M | 146k | 122.94 | |
| X4 Pharmaceuticals Com New (XFOR) | 10.0 | $17M | 3.7M | 4.67 | |
| Compass Pathways Sponsored Ads (CMPS) | 6.7 | $12M | 820k | 14.15 | |
| Surrozen Com New (SRZN) | 5.7 | $10M | 385k | 25.95 | |
| Aclaris Therapeutics (ACRS) | 5.6 | $9.7M | 1.8M | 5.29 | |
| Sionna Therapeutics (SION) | 5.0 | $8.7M | 197k | 43.99 | |
| Inhibikase Therapeutics Com New (IKT) | 4.5 | $7.8M | 3.8M | 2.03 | |
| Pharvaris N V (PHVS) | 4.0 | $6.9M | 199k | 34.58 | |
| Karyopharm Therapeutics Com New (KPTI) | 3.9 | $6.7M | 686k | 9.77 | |
| Septerna (SEPN) | 3.7 | $6.5M | 195k | 33.49 | |
| Inflarx Nv (IFRX) | 3.7 | $6.5M | 2.9M | 2.24 | |
| Cyclerion Therapeutics (CYCN) | 3.2 | $5.6M | 1.7M | 3.39 | |
| Korro Bio (KRRO) | 3.1 | $5.3M | 405k | 13.18 | |
| Uniqure Nv SHS (QURE) | 2.1 | $3.7M | 79k | 46.06 | |
| Athira Pharma (LONA) | 2.1 | $3.6M | 394k | 9.19 | |
| Damora Therapeutics Com New (DMRA) | 2.1 | $3.6M | 139k | 26.01 | |
| MoonLake Immunotherapeutics Class A Ord (MLTX) | 2.0 | $3.4M | 176k | 19.47 | |
| Adlai Nortye Sponsored Ads (ANL) | 1.5 | $2.6M | 226k | 11.50 | |
| Tyra Biosciences (TYRA) | 1.4 | $2.4M | 75k | 31.94 | |
| Nuvectis Pharma (NVCT) | 1.1 | $1.8M | 100k | 18.39 | |
| Gossamer Bio (GOSS) | 1.1 | $1.8M | 11M | 0.16 | |
| Milestone Pharmaceuticals (MIST) | 1.0 | $1.7M | 1.3M | 1.34 | |
| Atyr Pharma Com New (ATYR) | 0.6 | $1.1M | 1.8M | 0.60 | |
| Instil Bio Com New (TIL) | 0.4 | $766k | 100k | 7.69 | |
| Tscan Therapeutics (TCRX) | 0.3 | $446k | 455k | 0.98 |
